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Experimental Procedures 
General. Unless otherwise noted, all chemicals and reagents for chemical reactions were 
obtained from commercial suppliers (Sigma-Aldrich, VWR, Alfa Aesar) and used without 
further purification.  Silica gel chromatography purifications were carried out using AMD Silica 
Gel 60, 230-400 mesh.  
1
H spectra were recorded on a Varian Inova 500 MHz instrument in 
CDCl3, and are referenced to the residual solvent peak. Synthetic reactions were monitored 
using thin layer chromatography (Merck 60 gel plates) using an UV-lamp for visualization.   
 
Chromatography. Analytical high-performance liquid chromatography (HPLC) was carried out 
using an Agilent 1200 series, and a Kromasil 100 C18 column (Peeke Scientific, 4.6 x 50 mm, 5 
µm). Semi-preparative HPLC was performed using an Agilent XDB-C18 (9.4 x 250 mm, 5 µm).  
Analytical chiral HPLC was conducted using a supercritical fluid chromatography (SFC) system 
with isopropanol and liquid CO2 as the mobile phase.  Chiralcel OB-H and OJ columns were 
used to separate sulfimide enantiomers (4.6 x 150 mm, 5 µM). Sulfides were all commercially 
available and sulfimide standards were prepared as reported.
1  
e.r. values determined by dividing 
the major peak area by the sum of the peak areas determined by SFC chromatography.   
 
Cloning and site-directed mutagenesis. pET22b(+) was used as a cloning and expression 
vector for all enzymes described in this study.  Site-directed mutagenesis on P411BM3-CIS T438S 
to generate P411BM3-CIS I263A T438S was performed using a modified QuickChange
TM
 
mutagenesis protocol.  The PCR products were gel purified, digested with DpnI, and directly 
transformed into E. coli strain BL21 (DE3).   
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Determination of P450 concentration.  Concentration of P450/P411 enzymes was 
accomplished by quantifying the amount of free hemin present in purified protein using the 
pyridine/hemochrome assay.
2
 
 
Protein expression and purification.  Enzymes used in purified protein experiments were 
expressed in BL21(DE3) E. coli cultures transformed with plasmid encoding P450 or P411 
variants.  Expression and purification was performed as described elsewhere,
3
 except that the 
shake rate was lowered to 130 RPM during expression.  Following expression, cells were 
pelleted and frozen at -20 °C. For purification, frozen cells were resuspended in buffer A (20 
mM tris, 20 mM imidazole, 100 mM NaCl, pH 7.5, 4 mL/g of cell wet weight) and disrupted by 
sonication (2 x 1 min, output control 5, 50% duty cycle; Sonicator 3000, Misonix, Inc.). To 
pellet insoluble material, lysates were centrifuged at 24,000 x g for 0.5 h at 4 °C.  Proteins were 
expressed in a construct containing a 6x-His tag and were consequently purified using a nickel 
NTA column (5 mL HisTrap HP, GE Healthcare, Piscataway, NJ) using an AKTAxpress 
purifier FPLC system (GE healthcare).  P450 or P411 enzymes were then eluted on a linear 
gradient from 100% buffer A 0% buffer B (20 mM tris, 300 mM imidazole, 100 mM NaCl, pH 
7.5) to 100 % buffer B over 10 column volumes (P450/P411 enzymes elute at around 80 mM 
imidazole).  Fractions containing P450 or P411 enzymes were pooled, concentrated, and 
subjected to three exchanges of phosphate buffer (0.1 M KPi pH 8.0) to remove excess salt and 
imidazole.  Concentrated proteins were aliquoted, flash-frozen on powdered dry ice, and stored 
at -20 °C until later use.   
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Typical procedure for small-scale sulfimidation bioconversions under anaerobic 
conditions using purified enzymes. Small-scale reactions (400 µL) were conducted 
anaerobically in 2 mL crimp vials as described previously.
3
 A solution of aryl sulfide in DMSO 
or methanol (100 mM, 10 µL) was added to the reaction vial via syringe, followed by 
arylsulfonyl azide (100 mM, 10 µL, DMSO).  Final concentrations of the reagents were 
typically: 2.5 mM aryl sulfide, 2.5 mM arylsulfonyl azide, 10 mM NADPH, 25 mM glucose, 5-
20 µM P450. To the vials were then added acetonitrile (460 µL) and internal standard (1,3,5 
trimethoxybenzene, 10 mM in 10% DMSO/90% acetonitrile, 1 mM final concentration).  This 
mixture was then transferred to a microcentrifuge tube, and centrifuged at 17,000 x g for 5 
minutes.  A portion (20 µL) of the supernatant was then analyzed by HPLC. Sulfimide 
formation was quantified by comparison of integrated peak areas of internal standard (1,3,5-
trimethoxy benzene, 1 mM or 1,3,5-trichlorobenzene, 1 mM) and sulfimide at 220 nm to a 
calibration curve made using synthetically produced sulfimide and internal standard.  
Coefficients determined from standard curves were multiplied by a dilution factor in order to 
obtain sulfimide concentrations in the reaction mixture.  Standard curves and response factors 
for products 8a-8d are presented in Figures S12-S15 below. For chiral HPLC, the quenched 
reaction mixture was extracted twice with ethyl acetate (2 x 350 µL), dried under a light argon 
stream and resuspended in acetonitrile (100 µL). 
 
Controls to confirm the enzymatic sulfimidation activity of variant P411BM3CIS T438S.  
Small-scale reactions (400 µL total volume) were set up and worked up as described above.  For 
the reaction containing hemin as catalyst, 10 µL of a hemin solution (1 mM in 50% DMSO-
H2O) was added to a final concentration of 25 µM.  TTNs were determined as described above 
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and are presented in Table S2.  CS denotes ‘complete system’ in which all components of the 
reactions as described above are present.  Variations from the complete system are denoted with 
a “- X” where X is the component removed.  
 
Synthesis of substrates and standards 
All sulfides presented in Table 2 were obtained from commercial sources (Sigma Aldrich, Alfa 
Aesar).  Sulfimide standards were synthesized as previously reported.
1
  
8a 
 
 
1
H NMR (500 MHz; CDCl3): δ = 7.71 (d, J = 8.0 Hz, 2H), 7.61 (d, J = 8.9 Hz, 2H), 7.15 
(d, J = 8.35 Hz, 2H), 6.96 (d, J = 8.9 Hz, 2H), 3.83 (s, 3H), 2.81 (s, 3H), 2.34 (s, 3H) 
8b 
 
 
1
H NMR (500 MHz; CDCl3): δ = 7.72 (d, J = 8.2 Hz, 2H), 7.57 (d, J = 8.2 Hz, 2H), 7.28 
(d, J = 7.3 Hz, 2H), 7.16 (d, J = 8.1 Hz, 2H), 2.82 (s, 3H), 2.39 (s, 3H), 2.35 (s, 3H) 
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8c 
 
 
1
H NMR (500 MHz; CDCl3): δ = 7.73 (d, J = 8.0 Hz, 2H), 7.48-7.33 (m, 4H), 7.17 (d, J = 
8.1 Hz, 2H), 2.82 (s, 3H), 2.36 (s, 3H), 2.35 (s, 3H) 
 
8d 
  
 
1
H NMR (500 MHz; CDCl3): δ = 7.72 (d, J = 7.8 Hz, 2H),  7.55-7.46 (m, 5H), 7.16 (d, J = 8.1 
Hz, 2H), 2.83 (s, 3H), 2.34 (s, 3H) 
The 
1
H NMR listings above for products 8a-8d matched those of characterized compounds.
4
 
 
Determination of initial rates.  Four 2-ml vials were charged with a stir bar, 10x oxygen 
depletion system
3
 (40 µL), and a solution of enzyme prior to crimp sealing with a silicon septum. 
Once sealed, the headspace was flushed with argon for at least 10 minutes. Concurrently, a 
sealed 6-mL vial charged with glucose (250 mM, 400 µL), NADPH (20 mM, 400 µL), and KPi 
(pH = 8.0, 0.1 M, 2.6 mL) was sparged for 10 minutes with argon. After degassing was 
complete, 340 µL of the reaction solution was transferred to the 2-mL vial via syringe. Sulfide 
(100 mM, 10 µL) was added to all four 2-mL vials followed quickly (less than 20 seconds) by 
tosyl azide (100 mM, 10 µL). The reactions were quenched at 1-2 minute intervals over 5-10 
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minutes by decapping and adding acetonitrile (460 µL). After 5 minutes of stirring, the vials 
were charged with internal standard and the reaction mixtures were transferred to 1.8 mL tubes, 
which were vortexed and centrifuged (14,000 x g, 5 min). The supernatant was transferred to a 
vial for analysis by HPLC.  Initial rates are plotted for individual enzymes referenced in the text 
in Figure S2, and for various substituted aryl sulfides in Figure S7.   
 
Visible absorbance spectroscopy and observation of resting states. To a semi-micro 
anaerobic cuvette, 8 µL of P411BM3CIS I263A T438S (400 µM) was added.  To obtain a 
spectrum of the ferric protein, 0.5 mL of degassed phosphate buffer was added to the cuvette 
and the visible spectrum was recorded from 650 to 400 nm.  To obtain a spectrum of the ferrous 
protein, the cuvette was sealed with a cap equipped with rubber septa and the headspace of the 
cuvette was purged with a gentle stream of Ar for 3 min.  A solution of NADPH (5 mM) was 
added to a 6 mL crimp vial and made anaerobic by sparging with Ar for 5 min.  The NADPH 
solution (0.5 mL) was then added to the anaerobic cuvette containing protein.  Visible spectra of 
the protein sample are recorded until a stable ferrous state is reached.  Representative spectra of 
the Fe(III)- and Fe(II)-protein are shown below (Figure S8 green and red lines, respectively).   
To determine the resting state of the protein in the unproductive catalytic cycle, a degassed 
solution of tosyl azide (2 µL, 400 mM in DMSO) was added to a fully reduced sample of ferrous 
protein.  The visible spectrum of the protein shifted to the ferric heme immediately and remained 
unchanged for 20 min.  Addition of an aliquot of organic solvent of similar volume did not cause 
the observed change in iron oxidation state.  At the end of 20 minutes (Figure S8, blue line), the 
cuvette was uncapped and the reaction mixture was worked up following the general procedure 
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for small scale reactions.  HPLC of the resulting solution confirmed that a substantial amount of 
azide is reduced to the corresponding sulfonamide.    
To determine the resting state of the protein during the sulfimidation reaction, a degassed 
solution of sulfide 7a (2 µL, 400 mM in DMSO) was added to the cuvette containing 
P411BM3CIS I263A T438S in the presence of NADPH.  A visible absorbance spectrum of the 
mixture was recorded to ensure that the oxidation state of iron heme is unchanged.  Next, a 
degassed solution of tosyl azide (2 µL, 400 mM in DMSO) was added to the cuvette.  Visible 
absorbance spectra of the solution were recorded at 5, 7, 12, 18, 22, 25 and 30 min (Figure S9).  
The appearance of ferrous heme is observed over time.  HPLC confirmed formation of both 
sulfimide and sulfonamide.  
 
Excess sulfide and azide slow addition experiments.  To assess the impact of sulfide 
concentration on overall productivity of reaction, sulfide was added to reaction ranging from 0.5 
eq to 4 eq relative to azide.  1 eq of azide denotes 1 mM in the small scale reactions described 
above.  Results are plotted in Figure S10 below as a ratio of the TTN for sulfimide vs. TTN for 
sulfonamide.  Slow addition was accomplished by adding 1 µL of a 100 mM (100 nmol) tosyl 
azide solution (DMSO) at 15 minute intervals to a reaction set up as described previously with 
0.4% catalyst loading, containing 2.5 mM 7a.  Azide was added over 150 minutes until 
equimolar final concentrations of sulfide and azide were achieved.  Results of the slow addition 
are presented in Figure S11.   
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Table S1. Mutations present in P450BM3 variants used in this work. 
  
Enzyme Mutations relative to wild-type P450BM3 
P450BM3 none 
P450BM3-T268A T268A 
P411BM3 C400S 
P411BM3-T268A T268A, C400S 
P450BM3-CIS T438S V78A, F87V, P142S, T175I, A184V, S226R, H236Q, 
E252G, A290V, L353V, I366V, T438S, E442K 
P411BM3-CIS T438S P450BM3-CIS C400S, T438S 
P411BM3-CIS A268T T438S P450BM3-CIS, A268T, C400S, T438S 
P411BM3 H2-A-10 P450BM3-CIS, L75A, L181A, C400S, 
P411BM3 H2-5-F10 P450BM3-CIS, L75A, I263A, C400S, L437A 
P411BM3 H2-4-D4 P450BM3-CIS, L75A, M177A, L181A, C400S, 
L437A, T438S  
 
 
 
 
 
 
 
 
 
Figure S1. Azides tested as nitrene sources for sulfimidation of thioanisole using the P411BM3-
CIS T438S enzyme. TTN = total turnover number. 
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Table S2. Control experiments using substrate 7c yielding products 8c (sulfimide) and 9 
(sulfonamide).  CS = complete system.  
 
Condition TTN 8c TTN 9 
P411BM3-CIS T438S (CS) 90 300 
CS - NADPH 1 2 
CS + Na2S2O4 + CO 2 40 
CS boiled enzyme 1 53 
CS aerobic 2.3 16 
Hemin + Na2S2O4 0 42 
CS - P411BM3-CIS T438S 0 21 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S2. Data used to determine initial rates of the reaction depicted in scheme above using 
the enzymes listed in figure legend. 
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Table S3. Initial rates determined from data presented in Figure S2 and TTNs presented in Table 
1. 
 
Enzyme Rate (nmol min-1) TTN 
P411BM3-CIS T438S 33  300 
P411BM3-H2-A-10 3.5 32 
P411BM3-H2-4-D4 5.9 84 
 
 
Table S4. Qualitative description of reaction productivity using para-methoxy aryl sulfide 7a 
and azides shown in Figure S1. 
 
Azide Productivity 
a
 
    1          +++ 
    2          + 
    3         nd 
b
 
    5          + 
    6         nd 
a
 + denotes relative amount of product, where +++ is the most productive reaction.  See Figures 
S26 and S27 for LC-MS verification of product formation for azides 2 and 4. 
b
 nd = none 
detected.   
 
 
Table S5.  Enantioselectivity of products 8a–8d with P411BM3-CIS T438S enzyme. 
 
 
 
Product e.r. R1 R2 
8a 74:26  -OMe -H 
8b 80:20 -Me -H 
8c 59:41 -H -Me 
8d 87:13 -H -H 
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Figure S3.  A) SFC trace of synthetic standard of 8a using Chiralpak OD-H column with 25% 
isopropanol/75% supercritical CO2 mobile phase.  B) Trace of P411BM3-CIS T438S produced 8a 
under same conditions as synthetic standard.  C) Trace of P411BM3-H2-5-F10 produced 8a.  D) 
Trace of P411BM3-CIS I263A T438S produced 8a, using 20 % isopropanol/80% supercritical 
CO2 mobile phase.   
 
 
Figure S4.  Top: SFC trace of 8b synthetic standard using Chiralpak OD-H column with 20% 
isopropanol/80% supercritical CO2 mobile phase.  Bottom: Trace of enzyme produced 8b. 
 
A 
B 
C 
D 
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Figure S5. Top: SFC trace of 8c synthetic standard using Chiralpak OJ column with 15% 
isopropanol/85% supercritical CO2 mobile phase.  Bottom: Trace of enzyme produced 8c.   
 
 
 
Figure S6. Top: SFC trace of 8d synthetic standard using Chiralpak OJ column with 15% 
isopropanol/85% supercritical CO2 mobile phase.  Bottom: Trace of enzyme produced 8d. 
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Figure S7. Data used to determine initial rates for reaction of substituted aryl sulfides with tosyl 
azide, using P411BM3-CIS T438S as catalyst.  Sulfimide products measured are as listed in Table 
2 of the text.   
 
 
 
 
 
Figure S8. Visible spectroscopy of Fe(III) (green) and Fe(II)-P411BM3CIS I263A T438S in the 
presence of NADPH (red), followed by azide addition (blue).   
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Figure S9.  Monitoring the iron heme during the sulfimidation reaction with azide and sulfide.  
As shown in Figure S8, the Soret peak for the Fe(III) state is obscured by NADPH.  Therefore 
the Q-band region (enlarged box from 530-640 nm) was used to assess the transition from Fe(III) 
to Fe(II) as reaction proceeds as described in the supplemental text.    
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Figure S10. Ratio of sulfimide TTN to sulfonamide TTN as sulfide concentration is varied, 
using P411BM3-CIS T438S enzyme, as shown in scheme.  Reactions were assembled as 
described above, with azide concentration held constant at 1 mM and sulfide concentration 
varied from 0.5 mM to 4 mM.   
 
 
Table S6:  Production of sulfimide 8a and sulfonamide 9 in the presence of varying levels of 
sulfide acceptor substrate, as described above.   
 
Sulfide Azide TTN 8a TTN 9 
0.5eq 1 eq 71 110 
1 eq 1 eq 97 100 
2 eq 1 eq 110 93 
3 eq 1 eq 130 85 
4 eq 1 eq 140 80 
 
 
 
    
P411
BM3
-CIS T438S (10 uM) 
8a 9 0.5 – 4 
eq 
1 eq 
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Figure S11. TTN values measured for slow addition vs. adding substrates simultaneously, using 
P411BM3-CIS T438S enzyme and the substrates shown in Figure S10.  Light gray bar shows 
TTN for sulfonamide, 9, dark gray shows TTN for the sulfimide, 8a.   
 
 
 
 
  
 
 
 
 
Figure S12: Standard curve for product 8a, showing response factor as ratio of product area to 
internal standard area as described above (y-axis) and concentration of product injected (x-axis). 
 
 
 
Concentration injected (mM) 
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Figure S13. Standard curve for product 8b. 
 
 
 
 
Figure S14. Standard curve for product 8c. 
 
 
 Concentration injected (mM) 
 Concentration injected (mM) 
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Figure S15. Standard curve for product 8d. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Concentration injected (mM) 
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Figure S16. Demonstration of enzymatic production of 8a 
Top: LC-MS 230 nm chromatogram of synthetic standard of 8a, confirmed by NMR.  Middle: 
Enzyme reaction containing putative 8a. Bottom: Mixture of enzyme reaction and synthetic 8a, 
showing coelution.   
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Figure S17. LC runs from figure S16 showing ESI-MS-(+) detection of total ion 
chromatogram (TIC) (major peak = 324, corresponding to 8a M+H+). 
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Figure S18. Demonstration of enzymatic production of 8b 
Top: LC-MS 230 nm chromatogram of synthetic standard of 8b, confirmed by NMR.  Middle: 
Enzyme reaction containing putative 8b. Bottom: Mixture of enzyme reaction and synthetic 8b, 
showing coelution.   
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Figure S19. LC runs from figure S18 showing ESI-MS-(+) detection of selected ions (mass 
window 307.5-308.5). 
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Figure S20. Demonstration of enzymatic production of 8c. 
Top: LC-MS 230 nm chromatogram of synthetic standard of 8c, confirmed by NMR.  Middle: 
Enzyme reaction containing putative 8c. Bottom: Mixture of enzyme reaction and synthetic 8c, 
showing coelution.   
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Figure S21. LC runs from figure S20 showing ESI-MS-(+) detection of selected ions (mass 
window 307.5-308.5). 
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Figure S22. Demonstration of enzymatic production of 8d 
Top: LC-MS 230 nm chromatogram of synthetic standard of 8d, confirmed by NMR.  Middle: 
Enzyme reaction containing putative 8d. Bottom: mixture of enzyme reaction and synthetic 8d, 
showing coelution.   
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Figure S23. LC runs from figure S22 showing ESI-MS-(+) detection of total ion chromatogram 
(major mass peak = 294 m/z corresponding to 8d M+H+). 
 
 
 
Figure S24. LC runs from reaction with P411BM3-CIS T438S with substrate 7e showing ESI-
MS-(+) detection of selected ions (mass window 321.5 – 322.5 m/z), demonstrating production 
of 8e. 
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Figure S25. Mass spectrum of peak identified in figure S24, showing M+H+ of product 8e.  
 
 
 
 
 
Figure S26. LC-MS chromatogram showing UV trace at 230 nm (top) and selected ions for 344 
m/z , corresponding to the M+H+ mass of the product of azide 2 with sulfide 7a. Note TIC 
timescale differs from due to instrument solvent delay.   
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Figure S27. LC-MS chromatogram showing UV trace at 230 nm (top) and selected ions for 262 
m/z, corresponding to the M+H+ mass of the product of azide 4 with sulfide 7a.  Note TIC 
timescale differs from chromatogram due to instrument solvent delay.  
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